Success Analysis - Basic Report

Therapy % Success Rate - By Therapy Failure Rate
Post Launch
By Therapy
  Preclinical-
Launch
Phase I-
Launch
Phase II-
Launch
Phase III-
Launch
Pre-registration-
Launch
Registration-
Launch
 
Anorectic/Antiobesity, A8A3  18  32  86  86  86  17
Antidiabetic, A10B  27  38  73  90  95  5
Hypolipaemic/Antiatherosclerosis, C10  34  48  85  95  95  5
Dependence treatment, N9A  40  50  60  75  75  33

Copyright © Informa UK Ltd 2006